AMAM 27.99 (+0.04%)
US02290A1025BiotechnologyBiotechnology

Ambrx Biopharma (AMAM) Stock Highlights

27.99 | +0.04%
2024-11-21 03:07:04
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, ARX305 among others.

Statistics

Range Today
27.98 28
Volume Today 1.38M
Range 1 Year
6.34 28.15
Volume 1 Year 314.81M
Range 3 Year
0.38 28.15
Volume 3 Year 739.37M
Range 10 Year
0.38 28.15
Volume 10 Year 739.37M

Highlights

Market Capitalization 1.77B (small)
Floating Shares 21.92M
Current Price 27.99
Price To Earnings 66.64
Price To Revenue 379.54
Price To Book 7.28
Earnings Per Share 0.42
Payout Ratio 0%

Performance

Latest +0.04%
1 Month +0.76%
3 Months +130.94%
6 Months +106.26%
1 Year +335.3%
3 Years +55.5%
5 Years +55.5%
10 Years +55.5%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.